Liu L - Search Results

1

Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.

Bergman AJ, Murphy G, Burke J, Zhao JJ, Valesky R, Liu L, Lasseter KC, He W, Prueksaritanont T, Qiu Y, Hartford A, Vega JM, Paolini JF. Bergman AJ, et al. Among authors: liu l. J Clin Pharmacol. 2004 Sep;44(9):1054-62. doi: 10.1177/0091270004268044. J Clin Pharmacol. 2004. PMID: 15317833 Clinical Trial.

2

Mechanistic studies on metabolic interactions between gemfibrozil and statins.

Prueksaritanont T, Zhao JJ, Ma B, Roadcap BA, Tang C, Qiu Y, Liu L, Lin JH, Pearson PG, Baillie TA. Prueksaritanont T, et al. Among authors: liu l. J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51. doi: 10.1124/jpet.301.3.1042. J Pharmacol Exp Ther. 2002. PMID: 12023536

3

Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

Rogers JD, Zhao J, Liu L, Amin RD, Gagliano KD, Porras AG, Blum RA, Wilson MF, Stepanavage M, Vega JM. Rogers JD, et al. Among authors: liu l. Clin Pharmacol Ther. 1999 Oct;66(4):358-66. doi: 10.1053/cp.1999.v66.a101208. Clin Pharmacol Ther. 1999. PMID: 10546919 Clinical Trial.

4

Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects.

Prueksaritanont T, Vega JM, Zhao J, Gagliano K, Kuznetsova O, Musser B, Amin RD, Liu L, Roadcap BA, Dilzer S, Lasseter KC, Rogers JD. Prueksaritanont T, et al. Among authors: liu l. J Clin Pharmacol. 2001 May;41(5):573-81. doi: 10.1177/00912700122010311. J Clin Pharmacol. 2001. PMID: 11361054 Clinical Trial.

5

Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects.

Migoya EM, Bergman A, Hreniuk D, Matthews N, Yi B, Roadcap B, Valesky R, Liu L, Riffel K, Groff M, Zhao JJ, Musson DG, Gambale J, Kosoglou T, Statkevich P, Lasseter KC, Laurent A, Johnson-Levonas AO, Murphy G, Gottesdiener K, Paolini JF. Migoya EM, et al. Among authors: liu l. Int J Clin Pharmacol Ther. 2006 Feb;44(2):83-92. doi: 10.5414/cpp44083. Int J Clin Pharmacol Ther. 2006. PMID: 16502768 Clinical Trial.

6

Robotic inhibition assay for determination of HMG-CoA reductase inhibitors in human plasma.

Fang W, Liu L, Hsieh JY, Zhao J, Matuszewski BK, Rogers JD, Dobrinska MR. Fang W, et al. Among authors: liu l. J Clin Lab Anal. 2002;16(5):209-15. doi: 10.1002/jcla.10046. J Clin Lab Anal. 2002. PMID: 12357448 Free PMC article.

7

Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.

Valesky RJ, Liu L, Musson DG, Zhao JJ. Valesky RJ, et al. Among authors: liu l. J Pharmacol Toxicol Methods. 2008 Jan-Feb;57(1):61-9. doi: 10.1016/j.vascn.2007.06.002. Epub 2007 Jun 23. J Pharmacol Toxicol Methods. 2008. PMID: 17651990

8

Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics--results from single oral dose studies in healthy volunteers.

Stoch SA, Zajic S, Stone JA, Miller DL, van Bortel L, Lasseter KC, Pramanik B, Cilissen C, Liu Q, Liu L, Scott BB, Panebianco D, Ding Y, Gottesdiener K, Wagner JA. Stoch SA, et al. Among authors: liu l, liu q. Br J Clin Pharmacol. 2013 May;75(5):1240-54. doi: 10.1111/j.1365-2125.2012.04471.x. Br J Clin Pharmacol. 2013. PMID: 23013236 Free PMC article. Clinical Trial.

9

In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.

Prueksaritanont T, Gorham LM, Ma B, Liu L, Yu X, Zhao JJ, Slaughter DE, Arison BH, Vyas KP. Prueksaritanont T, et al. Among authors: liu l. Drug Metab Dispos. 1997 Oct;25(10):1191-9. Drug Metab Dispos. 1997. PMID: 9321523

10

Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection.

Liu L, Zhang R, Zhao JJ, Rogers JD, Hsieh JY, Fang W, Matuszewski BK, Dobrinska MR. Liu L, et al. J Pharm Biomed Anal. 2003 Apr 24;32(1):107-23. doi: 10.1016/s0731-7085(03)00023-2. J Pharm Biomed Anal. 2003. PMID: 12852453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,262 results

Search Page